Factors associated with Prostate Cancer in Prostate Needle Biopsy

Proposal
1626

Title of Proposed Research

Lead Researcher

Daniel M. Moreira

Affiliation

University of Illinois at Chicago

Funding Source

None

Potential Conflicts of Interest

None

Data Sharing Agreement Date

16 December 2016

Lay Summary

Prostate cancer is the most common cancer and the second most common cause of cancer-related death in men in the United States.
In this study we seek to determine the factors that are most predictive of having prostate cancer at the time of prostate needle biopsy, including patients' demographics, medications and laboratory tests. We expect that, by analyzing such variables in multivariate models, we will be able to determine the independent predictors of cancer in prostate needle biopsy which may allow a reduction in unnecessary biopsies.

Study Data Provided

[{ "PostingID": 369, "Title": "GSK-ARI40006", "Description": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer" },{ "PostingID": 1276, "Title": "GSK-ARI103094", "Description": "ARI103094-Follow-Up Study for REDUCE Study Subjects" }]

Statistical Analysis Plan

Publication Citation

https://doi.org/10.1016/j.juro.2018.06.018